Cargando…
A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma
BACKGROUND: In the current study we present a validated miRNA signature to predict pathologic complete response (pCR) to neoadjuvant chemoradiation in esophageal adenocarcinoma. METHODS: Three patient cohorts (discovery, n = 10; model, n = 43; and validation, n = 65) with locally advanced esophageal...
Autores principales: | Skinner, Heath D, Lee, Jeffrey H, Bhutani, Manoop S, Weston, Brian, Hofstetter, Wayne, Komaki, Ritsuko, Shiozaki, Hironori, Wadhwa, Roopma, Sudo, Kazuki, Elimova, Elena, Song, Shumei, Ye, Yuanqing, Huang, Maosheng, Ajani, Jaffer, Wu, Xifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239178/ https://www.ncbi.nlm.nih.gov/pubmed/25091571 http://dx.doi.org/10.1002/cncr.28911 |
Ejemplares similares
-
Evolution of gastric surgery techniques and outcomes
por: Shiozaki, Hironori, et al.
Publicado: (2016) -
Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients
por: Wadhwa, Roopma, et al.
Publicado: (2017) -
Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance
por: Elimova, Elena, et al.
Publicado: (2017) -
Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors
por: Ajani, Jaffer A, et al.
Publicado: (2018) -
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial
por: Shimodaira, Yusuke, et al.
Publicado: (2018)